(Q85007169)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996291%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

Activated monocytes augment TRAIL-mediated cytotoxicity by human NK cells through release of IFN-γ (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996291%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996291%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Pádraig D'arcy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996291%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Erik Wennerberg

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996291%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Charlotte Rolny

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996291%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Andreas Lundqvist

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996291%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Majken Lidén

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996291%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Jin Hu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996291%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Ola Winqvist

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996291%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

26 October 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996291%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

13 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996291%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996291%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996291%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

249-257

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996291%20AND%20SRC:MED&resulttype=core&format=json

Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect

13 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242735

7 January 2021

DNAM-1/CD155 interactions promote cytokine and NK cell-mediated suppression of poorly immunogenic melanoma metastases

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242735

7 January 2021

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242735

7 January 2021

Roles of the NKG2D immunoreceptor and its ligands

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242735

7 January 2021

The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242735

7 January 2021

Involvement of activating NK cell receptors and their modulation in pathogen immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242735

7 January 2021

Activation of NK cell cytotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242735

7 January 2021

Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242735

7 January 2021

Treatment persistence with monthly zoledronic acid is associated with lower risk and frequency of skeletal complications in patients with breast cancer and bone metastasis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242735

7 January 2021

Individual Vgamma2-Jgamma1.2+ T cells respond to both isopentenyl pyrophosphate and Daudi cell stimulation: generating tumor effectors with low molecular weight phosphoantigens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242735

7 January 2021

Induction of gammadelta T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242735

7 January 2021

Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242735

7 January 2021

Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242735

7 January 2021

DC-like cell-dependent activation of human natural killer cells by the bisphosphonate zoledronic acid is regulated by γδ T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242735

7 January 2021

Coculturing dendritic cells with zoledronate acid efficiently enhance the anti-tumor effects of cytokine-induced killer cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242735

7 January 2021

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242735

7 January 2021

Interferon-γ-producing immature myeloid cells confer protection against severe invasive group A Streptococcus infections

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242735

7 January 2021

A novel dendritic cell subset involved in tumor immunosurveillance

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242735

7 January 2021

TRAIL-induced cell death cooperates with IFN-γ activation in the graft-versus-tumor effect against colon tumors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242735

7 January 2021

Eradication of established tumors in mice by a combination antibody-based therapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242735

7 January 2021

Enhanced proliferation and increased IFN-gamma production in T cells by signal transduced through TNF-related apoptosis-inducing ligand

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242735

7 January 2021

Effect of acetaminophen and fluvastatin on post-dose symptoms following infusion of zoledronic acid

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242735

7 January 2021

Zoledronic acid inhibits macrophage SOCS3 expression and enhances cytokine production

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242735

7 January 2021

Bisphosphonates inhibit phosphorylation of signal transducer and activator of transcription 3 and expression of suppressor of cytokine signaling 3: implications for their effects on innate immune function and osteoclastogenesis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242735

7 January 2021

Peripheral blood monocytes are responsible for gammadelta T cell activation induced by zoledronic acid through accumulation of IPP/DMAPP.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242735

7 January 2021

4-1BB-ligand is regulated on human dendritic cells and induces the production of IL-12.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242735

7 January 2021

Bortezomib and depsipeptide sensitize tumors to tumor necrosis factor-related apoptosis-inducing ligand: a novel method to potentiate natural killer cell tumor cytotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242735

7 January 2021

p53-Independent up-regulation of a TRAIL receptor DR5 by proteasome inhibitors: a mechanism for proteasome inhibitor-enhanced TRAIL-induced apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242735

7 January 2021

Breast-cancer adjuvant therapy with zoledronic acid

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242735

7 January 2021

Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242735

7 January 2021

CD54 is a surrogate marker of antigen presenting cell activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242735

7 January 2021

Inhibition of proteasome deubiquitinating activity as a new cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242735

7 January 2021

Identifiers

DOI

10.1002/EJI.201242735

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996291%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference